tiprankstipranks
Akebia Therapeutics (AKBA)
NASDAQ:AKBA

Compare Akebia Therapeutics (AKBA) vs. Competitors

1,628 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Akebia Therapeutics
$1.43
$377.71M
-8.72
-17.06%
3 Buy
0 Hold
0 Sell
Strong Buy
Oruka Therapeutics
$63.60
$3.15B
-13.11
787.03%
13 Buy
0 Hold
0 Sell
Strong Buy
Theravance Biopharma
$16.55
$852.21M
3.90
94.02%
3 Buy
3 Hold
0 Sell
Moderate Buy
Vir Biotechnology
$9.83
$1.57B
-1.91
71.85%
8 Buy
0 Hold
0 Sell
Strong Buy
ProKidney
$1.85
$573.64M
-3.93
226.46%
2 Buy
2 Hold
1 Sell
Hold
ArriVent BioPharma, Inc.
$25.25
$1.20B
-4.65
55.18%
9 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AKBA
Akebia Therapeutics
1.41
-0.14
-9.03%
ORKA
Oruka Therapeutics
63.60
56.23
762.96%
TBPH
Theravance Biopharma
16.55
8.16
97.26%
VIR
Vir Biotechnology
9.83
4.55
86.17%
PROK
ProKidney
1.90
1.29
211.48%
AVBP
ArriVent BioPharma, Inc.
27.25
10.39
61.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts